Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Sodium salicylate 325 mg gastro-resistant oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium salicylate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely sodium salicylate 650 milligram/1 each gastro-resistant oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium salicylate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sodium salicylate-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium salicylate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 150 mg and sodium salicylate 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium salicylate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing paracetamol and sodium salicylate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium salicylate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 150 mg and sodium salicylate 100 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium salicylate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Paracetamol 150 mg and sodium salicylate 100 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Sodium salicylate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Paracetamol 150 mg and sodium salicylate 100 mg oral tablet |
Has precise active ingredient |
False |
Sodium salicylate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing sodium salicylate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium salicylate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol- and sodium salicylate-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium salicylate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol and sodium salicylate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium salicylate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium salicylate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium salicylate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only sodium salicylate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium salicylate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol and sodium salicylate only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium salicylate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium salicylate 325 mg gastro-resistant oral tablet |
Has precise active ingredient |
True |
Sodium salicylate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sodium salicylate 325 mg gastro-resistant oral tablet |
Has basis of strength substance (attribute) |
True |
Sodium salicylate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium salicylate 650 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sodium salicylate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sodium salicylate 650 milligram/1 each gastro-resistant oral tablet (clinical drug) |
Has precise active ingredient |
True |
Sodium salicylate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 150 mg and sodium salicylate 100 mg oral tablet |
Has precise active ingredient |
True |
Sodium salicylate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Paracetamol 150 mg and sodium salicylate 100 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Sodium salicylate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |